OBJECTIVES: AIDS is caused by CD4 T-cell depletion. Although combination antiretroviral therapy can restore blood T-cell numbers, the clonal diversity of the reconstituting cells, critical for immunocompetence, is not well defined. METHODS: We performed an extensive analysis of parameters of thymic function in perinatally HIV-1-infected (n = 39) and control (n = 28) participants ranging from 13 to 23 years of age. CD4 T cells including naive (CD27 CD45RA) and recent thymic emigrant (RTE) (CD31/CD45RA) cells, were quantified by flow cytometry. Deep sequencing was used to examine T-cell receptor (TCR) sequence diversity in sorted RTE CD4 T cells. RESULTS: Infected participants had reduced CD4 T-cell levels with predominant depletion of the memory subset and preservation of naive cells. RTE CD4 T-cell levels were normal in most infected individuals, and enhanced thymopoiesis was indicated by higher proportions of CD4 T cells containing TCR recombination excision circles. Memory CD4 T-cell depletion was highly associated with CD8 T-cell activation in HIV-1-infected persons and plasma interlekin-7 levels were correlated with naive CD4 T cells, suggesting activation-driven loss and compensatory enhancement of thymopoiesis. Deep sequencing of CD4 T-cell receptor sequences in well compensated infected persons demonstrated supranormal diversity, providing additional evidence of enhanced thymic output. CONCLUSION: Despite up to two decades of infection, many individuals have remarkable thymic reserve to compensate for ongoing CD4 T-cell loss, although there is ongoing viral replication and immune activation despite combination antiretroviral therapy. The longer term sustainability of this physiology remains to be determined.
OBJECTIVES:AIDS is caused by CD4 T-cell depletion. Although combination antiretroviral therapy can restore blood T-cell numbers, the clonal diversity of the reconstituting cells, critical for immunocompetence, is not well defined. METHODS: We performed an extensive analysis of parameters of thymic function in perinatally HIV-1-infected (n = 39) and control (n = 28) participants ranging from 13 to 23 years of age. CD4 T cells including naive (CD27 CD45RA) and recent thymic emigrant (RTE) (CD31/CD45RA) cells, were quantified by flow cytometry. Deep sequencing was used to examine T-cell receptor (TCR) sequence diversity in sorted RTE CD4 T cells. RESULTS: Infected participants had reduced CD4 T-cell levels with predominant depletion of the memory subset and preservation of naive cells. RTE CD4 T-cell levels were normal in most infected individuals, and enhanced thymopoiesis was indicated by higher proportions of CD4 T cells containing TCR recombination excision circles. Memory CD4 T-cell depletion was highly associated with CD8 T-cell activation in HIV-1-infectedpersons and plasma interlekin-7 levels were correlated with naive CD4 T cells, suggesting activation-driven loss and compensatory enhancement of thymopoiesis. Deep sequencing of CD4 T-cell receptor sequences in well compensated infected persons demonstrated supranormal diversity, providing additional evidence of enhanced thymic output. CONCLUSION: Despite up to two decades of infection, many individuals have remarkable thymic reserve to compensate for ongoing CD4 T-cell loss, although there is ongoing viral replication and immune activation despite combination antiretroviral therapy. The longer term sustainability of this physiology remains to be determined.
Authors: Nancy J Halnon; Beth Jamieson; Mark Plunkett; Christine M R Kitchen; Thao Pham; Paul Krogstad Journal: Pediatr Res Date: 2004-11-05 Impact factor: 3.756
Authors: Otto O Yang; Joseph Church; Christina M R Kitchen; Ryan Kilpatrick; Ayub Ali; Yongzhi Geng; M Scott Killian; Rachel Lubong Sabado; Hwee Ng; Jeffrey Suen; Yvonne Bryson; Beth D Jamieson; Paul Krogstad Journal: J Virol Date: 2005-12 Impact factor: 5.103
Authors: F Javier Ibarrondo; Peter A Anton; Marie Fuerst; Hwee L Ng; Johnson T Wong; Jose Matud; Julie Elliott; Roger Shih; Mary Ann Hausner; Charles Price; Lance E Hultin; Patricia M Hultin; Beth D Jamieson; Otto O Yang Journal: J Virol Date: 2005-04 Impact factor: 5.103
Authors: Jeffrey M Harris; Mette D Hazenberg; Jean-François Poulin; Dana Higuera-Alhino; Diane Schmidt; Michael Gotway; Joseph M McCune Journal: Clin Immunol Date: 2005-05 Impact factor: 3.969
Authors: Jason C Lee; Maria Ines Boechat; Marvin Belzer; Joseph A Church; Jaime De Ville; Karin Nielsen; Stephanie Weston; Yongzhi Geng; Theresa Dunaway; Christina Kitchen; Paul A Krogstad Journal: AIDS Date: 2006-03-21 Impact factor: 4.177
Authors: Salvador Resino; Elena Seoane; Alicia Pérez; Ezequiel Ruiz-Mateos; Manuel Leal; Maria A Muñoz-Fernández Journal: BMC Infect Dis Date: 2006-07-13 Impact factor: 3.090
Authors: Sara Ferrando-Martinez; Rebeca S De Pablo-Bernal; Marta De Luna-Romero; Santiago J De Ory; Miguel Genebat; Yolanda M Pacheco; Francisco J Parras; Marta Montero; Jose Ramón Blanco; Felix Gutierrez; Jesus Santos; Francisco Vidal; Richard A Koup; María Ángeles Muñoz-Fernández; Manuel Leal; Ezequiel Ruiz-Mateos Journal: Clin Infect Dis Date: 2017-05-01 Impact factor: 9.079
Authors: Florin Tuluc; Sergei Spitsin; Nancy B Tustin; Jennifer B Murray; Richard Tustin; Laura A Schankel; Andrew Wiznia; Sharon Nachman; Steven D Douglas Journal: AIDS Res Hum Retroviruses Date: 2016-10-18 Impact factor: 2.205